Abstract Two primary chitinases have been identiWed in humans-acid mammalian chitinase (AMCase) and chitotriosidase (CHIT1). Mammalian chitinases have been observed to aVect the host's immune response. The aim of this study was to test for association between genetic variation in the chitinases and phenotypes related to chronic obstructive pulmonary disease (COPD). Polymorphisms in the chitinase genes were selected based on previous associations with respiratory diseases. Polymorphisms that were associated with lung function level or rate of decline in the Lung Health Study (LHS) cohort were analyzed for association with COPD aVection status in four other COPD case-control populations. Chitinase activity and protein levels were also related to genotypes. In the caucasian LHS population, the baseline forced expiratory volume in one second (FEV 1 ) was signiWcantly diVerent between the AA and GG genotypic groups of the AMCase rs3818822 polymorphism. Subjects with the GG genotype had higher AMCase protein and chitinase activity compared with AA homozygotes. For CHIT1 rs2494303, a signiWcant association was observed between rate of decline in FEV 1 and the diVerent genotypes. In the African American LHS population, CHIT1 rs2494303 and AMCase G339T genotypes were associated with rate of decline in FEV 1 . Although a
case-control populations. Chitinase activity and protein levels were also related to genotypes. In the caucasian LHS population, the baseline forced expiratory volume in one second (FEV 1 ) was signiWcantly diVerent between the AA and GG genotypic groups of the AMCase rs3818822 polymorphism. Subjects with the GG genotype had higher AMCase protein and chitinase activity compared with AA homozygotes. For CHIT1 rs2494303, a signiWcant association was observed between rate of decline in FEV 1 and the diVerent genotypes. In the African American LHS population, CHIT1 rs2494303 and AMCase G339T genotypes were associated with rate of decline in FEV 1 . Although a signiWcant eVect of chitinase gene alleles was found on lung function level and decline in the LHS, we were unable to replicate the associations with COPD aVection status in the other COPD study groups.
Introduction
Chitin is the second most abundant polysaccharide found in nature and functions as a major structural component in fungi, crustaceans, and insects, but not in mammals. Chitinases are enzymes characterized by their ability to hydrolytically cleave chitin. In mammals, two primary chitinases have been identiWed-acid mammalian chitinase (AMCase) and chitotriosidase (CHIT1). In addition to their ability to cleave either inhaled or ingested exogenous chitin, mammalian chitinases have been observed to aVect the host's immune response (Lee 2009 ). Recent studies have shown an association between the chitinase family of proteins and inXammatory lung diseases. For instance, high levels of AMCase in the lung were observed in a mouse model of asthma (Zhu et al. 2004) . CHIT1 levels were elevated in the bronchoalveolar lavage Xuid of smokers with chronic obstructive pulmonary disease (COPD) (Létuvé et al. 2010) . A chitinase-like protein, commonly known as YKL-40, has also been discovered in mammals. Unlike AMCase and CHIT1, YKL-40 binds chitin polymers but lacks the active site residues necessary for cleavage. Nevertheless, genetic variants in the gene have been shown to inXuence levels of the protein and susceptibility to asthma (Chupp et al. 2007; Ober et al. 2008 ). In addition, elevated levels of this protein in the lung have been found in patients with COPD (Létuvé et al. 2008) . Moreover, studies show that chitin has the ability to recruit and activate immune cells that are involved in the development of COPD, suggesting an important role of chitinases and chitinase-like proteins in the disease (Lee et al. 2008) .
Although these studies suggest the involvement of chitinase and chitinase-like proteins in COPD, the underlying mechanism remains to be determined. It is possible that the presence of chitinase may result in changes to the immune response, which could lead to more frequent exacerbations and ultimately increased rate of decline in lung function. COPD is a lung disease characterized by airXow limitation that is not fully reversible. Smoking is a key causal factor in the disease; however, only a fraction of all smokers develop COPD, suggesting a genetic susceptibility (Khoury et al. 1985) . Therefore, the aim of this study was to test for association between genetic variation in the chitinases and phenotypes related to COPD. Polymorphisms in the genes encoding the chitinase and chitinase-like proteins were assayed to determine their association with lung function phenotypes in smokers. We hypothesized that these gene variants aVect the baseline levels and rate of decline of lung function of smokers with mild-moderate COPD.
Materials and methods

Study participants
The participants in the primary analysis included in the present study were from the NHLBI-sponsored Lung Health Study (LHS) cohort previously described in detail (Connett et al. 1993) . BrieXy, the participants were all smokers with evidence of lung function impairment. Lung function at the start of the study was measured as forced expiratory volume in 1 s (FEV 1 ) as a percentage of predicted value. The change in lung function, measured as change in FEV 1 per year over a Wve-year period, was the main outcome measure of the LHS. Of the 5,887 total participants in the cohort, DNA samples and phenotypic data were available for 4,344 subjects. Informed consent was obtained from all participants and this study received the approval of the Providence Health Care Research Ethics Board. Table 1 provides the characteristics of the LHS participants (caucasians = 4,123; African-Americans = 164; other = 48). The single nucleotide polymorphisms (SNPs) that showed association with COPD in the LHS cohort were examined in four case-control cohorts, in which genome-wide association study data were available: (1) a case-control population from Norway (GenKOLS), (2) the National Emphysema Treatment Trial (NETT) cases and Normative Aging Study (NAS) controls, (3) the COPD cases and smoking controls of the ECLIPSE study (protocol number SCO104960) (Vestbo et al. 2008) , and (4) the Wrst 1,000 COPDGene study subjects ( Table 2) . Details of these populations have been previously described (Cho et al. 2010 (Cho et al. , 2011 .
Gene variants
The SNPs in the chitinase and chitinase-like genes in this study were selected based on previous associations with respiratory diseases. Table 3 shows a brief description of the polymorphisms. SNP rs3818822 in the CHIA gene (which encodes for the AMCase protein) has been previously associated with asthma in a case-control study from Germany (Bierbaum et al. 2005) . Another SNP in the CHIA gene, G339T, has also been previously associated with asthma among African American subjects in several populations (Seibold et al. 2009) . A 24-bp duplication in exon 10 in the CHIT1 gene results in aberrant splicing leading to the deletion of 87 nucleotides, producing an inactive form of the protein due to the lack of 29 amino acids. This polymorphism has been associated with reduced chitinase activity in the lungs of smokers (Seibold et al. 2008) . The CHI3L1 gene encodes the YKL-40 protein. SNP rs4950928 in CHI3L1 has been associated with asthma in both a Hutterite population and outbred populations, as well as with serum levels of the protein (Ober et al. 2008 ).
Tag SNP selection for the 24-bp duplication in CHIT1
To select an SNP that acts as a surrogate for the 24-bp duplication in the CHIT1 gene, 44 Coriell samples (Coriell Institute for Medical Research, Camden, NJ, USA) were genotyped for the duplication. The 24-bp duplication in the CHIT1 gene was assayed using electrophoresis on a 2% agarose gel of an ampliWcation product containing the duplication site. The region containing the duplication was ampliWed using a PCR cocktail that included 5 ng of genomic DNA, 0.2 M primers, 0.2 mM dNTPs, 1.5 L PCR buVer (Invitrogen), and 0.2 L Taq DNA polymerase (5 U/ L). PCR cycling conditions were as follows: 95°C for 15 min, 40 cycles of 95°C for 15 s, 60°C for 15 s, 72°C for (Ober et al. 2008) 15 s, and a Wnal extension at 72°C for 10 min. The results were compared with genotype data from SNPs within 100 kb of the duplication using the International HapMap Project database (http://hapmap.ncbi.nlm.nih.gov, accessed on 18 February 2010). Linkage disequilibrium was calculated using the CubeX algorithm (Gaunt et al. 2007 ).
Genotyping
DNA from blood samples of the LHS subjects was whole genome ampliWed using the REPLI-g Mini Kit (Qiagen, Mississauga, ON, Canada) prior to genotyping. Genotyping was performed using commercially available TaqMan assays (Applied Biosystems, Foster City, CA, USA). The assays used are as follows: assay ID for rs3818822 = C_25984541_20; G339T = AHXOFUG; rs2494303 = C_424861_10; rs4950 928 = C_27832042_10. For each assay, 5 ng of DNA was used for allelic discrimination.
Potential eVect of missense polymorphism in the CHIA gene
To determine the potential eVect of the missense polymorphism, rs3818822 (Gly102Arg), we used the SIFT and PolyPhen algorithms (http://sift.jcvi.org and http://genetics.bwh.harvard.edu/pph/), programs that predict the consequence of a polymorphism based on sequence homology and the physical properties of the amino acids.
AMCase protein levels SDS-PAGE for AMCase in bronchoalveolar lavage (BAL) Xuid had been previously performed (Seibold et al. 2008) and using these data AMCase protein levels in BAL were examined between the GG (n = 18) and AG (n = 5) genotypes (subjects with AA genotype were not available).
Chitinase activity
To determine the eVect of rs3818822 on chitinase activity, we used data from a chitinase activity assay that was previously performed (Seibold et al. 2008) . Chitinase activity levels were examined between the GG (n = 33) and AG/AA (AG = 9; AA = 1) genotypes.
Statistical analyses
Agreement of the genotype distributions with Hardy-Weinberg equilibrium in the LHS samples was assessed using a 2 goodness-of-Wt analysis. The LHS subjects were then stratiWed into caucasian and African American populations for further analyses (other ethnicities were excluded due to small sample sizes). The two outcomes used were mean baseline and rate of decline of post-bronchodilator FEV 1 , expressed as a percent of predicted value. Statistical analyses were performed by multivariate linear regression analysis. Age, sex, and smoking history (pack-years) were adjusted for when performing association analyses to determine the inXuence of each gene variant on the outcomes. The JMP 5.1 statistical software package (SAS Institute Inc., Cary, NC, USA) was used for analysis of the relationship between the genetic variants and the measures of lung function in the LHS. Analysis of the additive model in the LHS data was done using the SimHap package (Carter et al. 2008) . For the AMCase protein levels and chitinase activity analyses, an unpaired two-tailed student's t test with Welch correction was performed. A p value <0.05 was considered to be signiWcant.
Results
Analysis of Hardy-Weinberg equilibrium
All four SNPs were in Hardy-Weinberg equilibrium (rs3818822, p value = 0.625; G339T, p value = 0.663; rs2494303, p value = 0.996; rs4950928, p value = 0.995).
CHIA polymorphism rs3818822
Genotyping of rs3818822 was successful for 4,025 LHS subjects (3,879 caucasians; 129 African Americans; 17 Hispanics excluded). In the caucasian population, there was a signiWcant decrease in baseline lung function associated with the AA genotype compared with the GG genotype (p = 0.0291). The AA genotype was associated with almost 3% decrease in baseline FEV 1 compared with the GG + AG genotypes combined (p = 0.0285). No signiWcant association was observed in the African American population, as shown in Table 4 . Furthermore, no signiWcant association was observed with rate of decline of FEV 1 . An association study of this SNP was then performed in the four case-control populations; however, no signiWcant associations were observed (Table 5) .
CHIA polymorphism G339T
Genotyping of G339T was successful for 3,407 LHS subjects (3,280 caucasians; 114 African Americans; 13 Hispanics excluded). This variant was associated with the rate of decline of FEV 1 in African American subjects (p = 0.0021). As shown in Table 4 , a slower rate of decline in lung function was associated with the GT genotype compared with the GG genotype (p = 0.0050). The TT genotype was associated with a signiWcant increase in rate of decline in lung function compared to the GG genotype (p = 0.0005). This result remained signiWcant (p = 0.008) after Bonferroni correction for multiple comparisons (4 SNPs and 4 outcomes). No signiWcant association of the SNP was detected with baseline FEV 1 or rate of decline of FEV 1 in the caucasian population.
CHIT1 polymorphism rs2494303
SNP rs2494303 was found to be in perfect linkage disequilibrium with the 24-bp duplication (r 2 = 1) and was chosen for further study. Subsequently, 281 LHS participants who had been previously genotyped for the duplication were genotyped for rs2494303 to validate the level of linkage disequilibrium with the duplication. We conWrmed the strong linkage disequilibrium between the 24-bp duplication and rs2494303 (DЈ = 1.0, r 2 = 0.974), and this SNP was used to genotype the remaining LHS samples. Genotyping of rs2494303 was successful for 3,802 subjects (3,661 caucasians; 126 African Americans; 15 Hispanics excluded). The variant was strongly associated with the rate of decline of FEV 1 in the caucasian population (p = 0.0083). In particular, a decrease in rate of lung function decline was associated with the AC genotype (heterozygous for duplication) compared to the CC genotype (p = 0.0021). Conversely, a faster rate of decline in lung function was associated with the AA genotype (homozygous for duplication) compared with the CC genotype, as shown in Table 4 (p = 0.0121). In the African American population, the AC genotype was associated with a faster rate of decline in lung function compared with the CC genotype (p = 0.0075). No signiWcant associations were observed with baseline FEV 1 in either population. An association study of this SNP was then performed in the four case-control populations; however, no signiWcant associations with case-control status (Table 5) or FEV 1 levels (data not shown) were observed.
CHI3L1 polymorphism rs4950928
Genotyping of rs4950928 was successful for 3,966 LHS subjects (3,829 caucasians; 121 African Americans; 16 Hispanics excluded). We did not detect any association of the rs4950928 polymorphism with baseline FEV 1 or rate of decline of FEV 1 in either population.
Potential eVect of missense polymorphism rs3818822
The CHIA gene variant rs3818822 is a missense polymorphism that results in a glycine to arginine change. The SIFT and PolyPhen algorithms predicted that the glycine to arginine substitution may damage protein function due to its close contact with the functional site and the distinct changes in charge and hydrophobicity which could potentially aVect folding of the protein.
AMCase protein levels
AMCase protein levels were examined between subjects with the GG and AG genotypes for rs3818822. It was determined that subjects with the GG genotype had higher BAL AMCase protein by over 2.4-fold compared with subjects who had the AG genotype, as shown in Fig. 1a (p = 0.0209).
Chitinase activity
Chitinase activity was determined in subjects with GG and AG/AA genotypes for rs3818822. As shown in Fig. 1b , it was found that subjects with the GG genotype had a higher BAL chitinase activity by over fourfold compared with subjects who had the AG/AA genotypes (p = 0.0475).
Discussion
CHIA codes for the human acid mammalian chitinase. In this study, we showed that the CHIA gene variant rs3818822 was signiWcantly associated with baseline FEV 1 in the LHS cohort. SpeciWcally, smokers with the AA genotype had a lower baseline FEV 1 compared to smokers with GG genotype and GG + AG genotypes combined. Previously, this SNP has been associated with asthma in adults and children, with the G allele associated with protection against asthma (Bierbaum et al. 2005) . The rs3818822 gene variant is a missense polymorphism that results in an amino acid change, Gly102Arg. This variation is located in close proximity to the AMCase active site. However, the functional eVect of rs3818822 is yet to be examined. Our hypothesis that the Gly102Arg substitution may aVect the Fig. 1 a EVect of rs3818822 on bronchoalveolar lavage AMCase protein levels ( §SEM) in subjects with the GG genotype (n = 18) and the AG genotype (n = 5); *P < 0.05 compared with the GG genotype. b EVect of rs3818822 on bronchoalveolar lavage chitinase activity ( §SEM) in subjects with the GG genotype (n = 33) and the AG/AA genotypes (n = 10); *P < 0.05 compared with the GG genotype functionality of the AMCase protein is supported by in silico analysis using the SIFT and PolyPhen algorithms, which predicted the polymorphism to be detrimental to the function of the protein. Furthermore, this study has found that the GG genotype was associated with higher AMCase protein levels and chitinase activity in BAL.
A previous study has documented that a splice variant of the AMCase protein is detectable in the lung; however, this variant is lacking exon 6, which contains the conserved active site residues required for enzymatic activity of the protein (Seibold et al. 2008 ). Since rs3818822 is located near the active site, one can postulate that the Arg102 isoform may have a similar eVect as the splice variant described in the previous study, i.e., result in a lack of catalytic activity of the protein. It is important to note, however, that the chitin-binding domain is located in exon 12, away from the active site. Thus, one can suggest that if the Arg102 isoform conserves its ability to bind chitin, the AMCase chitin-binding complex may act as a "chi-lectin" to modulate the immune response. It is possible that the complex stimulates pro-inXammatory responses, leading to lung function impairment in COPD. The idea of chitin as a potential immunological adjuvant has been explored in previous studies (Da Silva et al. 2010 ). An alternative hypothesis is that the Gly102Arg change alters the tertiary structure of the protein and thus modiWes chitin binding, despite being located far from the chitin-binding domain in the amino acid sequence. Further research is needed to diVerentiate between these hypotheses. Nonetheless, our present study shows a genetic association between an AMCase polymorphism and level of lung function in the LHS cohort.
The fact that the rs3818822 gene variant was associated with baseline FEV 1 but not rate of decline in FEV 1 suggests that AMCase may not contribute to the progression of lung function decline, but rather may have a role in lung development or early impairment of lung function. A comparison with a matched cohort of healthy subjects is required to complement this observation. The other CHIA gene variant examined was the G339T located in the fourth exon. This study illustrated that this SNP is associated with the rate of decline in FEV 1 in African Americans. The minor T allele of this SNP was found to be associated with protection against asthma among African American subjects (Seibold et al. 2009 ). The presence of a single T allele was shown to be associated with a slower rate of decline in lung function compared with the GG genotype. The eVect was not consistent in subjects with the TT genotype; however, the sample size (n = 5) was low in this analysis.
CHIT1 encodes for the human chitinase, chitotriosidase. Unlike AMCase, this chitinase has previously been implicated in COPD. It was observed that CHIT1 is responsible for chitinolytic activity in the lung and is elevated in the lungs of patients with COPD (Létuvé et al. 2010) . Furthermore, the 24-bp duplication allele results in a nonfunctional protein and is associated with a lack of CHIT1 activity (Seibold et al. 2008) . In this study, we found an association between a genetic variant in CHIT1 and the rate of change in lung function. Smokers in the LHS cohort who were homozygous for an SNP, which is in linkage disequilibrium with the duplication, had a faster rate of decline in FEV 1 . This implies that smokers without a functional isoform of CHIT1 may develop a faster rate of decline of their lung function. Thus, the study suggests an active form of CHIT1 may be protective against rapid disease progression in smokers who develop COPD. This duplication has been examined in coronary artery disease and asthma; however, no association was found (Piras et al. 2007) .
CHI3L1 encodes for the chitinase-like protein, YKL-40. The rs4950928 gene variant was shown to be associated with reduced lung function in asthmatics, as well as with schizophrenia (Ober et al. 2008; Zhao et al. 2007 ); however, in this study we found no signiWcant association with the level or rate of decline in lung function in smokers who had mild/moderate COPD. Since all of the participants in the LHS were smokers, it is possible that this strong environmental factor may have overwhelmed the eVect of the rs4950928 polymorphism. This SNP is located in the core promoter of CHI3L1, within the binding site for the MYC and MAX transcription factors. The G allele is known to disrupt binding of these transcription factors, resulting in reduced transcription and lower mRNA levels, thus reducing the levels of the YKL-40 protein (Zhao et al. 2007 ).
Even though we were not able to replicate these associations with COPD aVection status in four COPD case-control populations, we were able to demonstrate genetic association of chitinase polymorphisms with measures of baseline lung function and lung function decline in the COPD patients from the LHS cohort. One can suggest that the associations in the LHS represent false-positive results; however, a limited number of polymorphisms was tested. The inconsistent results may be due to the diVerent demographics of the cohorts involved; for instance, the LHS participants were considerably younger than the subjects in the other cohorts. It is possible that the chitinase polymorphisms are risk factors early in the pathogenesis of COPD, but their inXuence could be more diYcult to detect in the later stages of the disease when the cumulative level of exposure to environmental factors (such as cigarette smoke) is larger. Another potential explanation for these results is that chitinase polymorphisms could inXuence lung function decline and/or severity in COPD subjects without inXuencing overall COPD susceptibility.
In the LHS, the associations of CHIA G339T with rate of decline of FEV 1 in the African Americans and CHIT1 rs2494303 with rate of decline of FEV 1 in the caucasians demonstrated that the values for heterozygotes were signiWcantly lower (or greater) than those for both homozygous classes. As there is no obvious biological rationale for this observation, these data must be viewed with caution until replicated in independent data sets.
Chitin has been shown to act as an immunological adjuvant by stimulating the production of various cytokines and chemokines (Lee et al. 2008 ). This suggests that chitinases such as CHIT1 may play a role in modulating the local and/ or circulating concentration of chitins in the body and regulating the immune response to this common polysaccharide. Theoretically, when exogenous chitin from sources such as fungi or dust mites is present in the lungs, CHIT1 acts by cleaving chitin which subsequently could prevent chitin from stimulating immune responses. Therefore, one can speculate that without active CHIT1, an accumulation of chitin may be present in the lungs, which could initiate an exaggerated pro-inXammatory response. This in turn could contribute to lung inXammation and ultimately to the onset and progression of COPD. Prior studies that have shown associations with chitinases and lung function were among subjects with asthma. The diVerences observed in this study may be due to the diVerent disease mechanisms between asthma and COPD. The method by which smoking causes the activation of chitinases is unclear. One hypothesis is that chitin particles are inhaled in tobacco smoke, due to fungal infection of the tobacco leaf (Verweij et al. 2000) and this may initiate the action of chitinases in the lungs.
In this study, we have demonstrated genetic associations between chitinase gene variants and lung function level and rate of decline in COPD patients from the LHS. In addition, a functional eVect of the rs3818822 polymorphism on AMCase levels and activity was demonstrated. Although a signiWcant eVect of chitinase gene alleles was found in the LHS, we were not able to replicate the associations with COPD aVection status in other COPD study populations. Therefore, we propose that chitinases may play a role in COPD disease risk in speciWc populations; however, more research is warranted to further clarify the precise function of chitinases in lung disease.
